GLPro Reference Guides

Neither guide is a sales page. Both cite the regulation, the FDA’s own plain-English restatement of it and the published trials, and both link every source in the sentence so a reader can check the claim against the page it came from.

They are written for the person standing in front of two bottles with a phone in one hand, which is where most of this decision is actually made.

A supplement label is the only document most buyers ever see, and it is the only one with rules attached. What has to be on it, in what units and in what order are all set in federal regulation, and the parts a seller may withhold are set just as precisely.

Once you can read a panel, comparing two products takes about a minute. Without that, the comparison is between two pieces of marketing copy — and marketing copy in this category is written to survive exactly that comparison.

So the first guide is about the document and the second is about the decision. In that order they take twenty minutes. In the other order the checklist is a set of questions with nowhere to look the answers up.

It starts with the panel. The federal rule sets out what a Supplement Facts panel has to carry: the heading, the serving size, the servings per container, and for each dietary ingredient a common or usual name with the amount by weight per serving.

Then the blend. The paragraph governing proprietary blends lets a seller pool the individual milligrams into one total on the same line as the blend name. It does not let the names go, and it does not let the order go.

Then what that order is worth: what a ranking plus a ceiling genuinely tells you, and what no amount of reading can extract from it. It closes on the practical case, which is what a shopper can do when a page names nothing at all.

Eight questions, asked in the order a buyer actually asks them: what is named, how much of it, who made it, what the guarantee says, who answers the phone, what the reviews say, what the seals mean, and what happens if nothing happens.

Around them sit the three things that decide how much any answer is worth. What a label is allowed to claim and where only a drug may go; what an advertiser has to hold before making a health claim at all; and what the trials in this category measured, in whom, and for how long.

It ends by scoring GLPro against the same eight questions, including the three it does not pass. A checklist that passes everything is worthless — which is the only reason that section sits on a website selling the product.

If you have not bought anything yet, read the label guide first and the checklist second. Twenty minutes, and the second half goes faster because the vocabulary is already in place.

If a bottle is already on the way, start with the checklist. It is organised around what you can still do — and the return window is one of the eight questions rather than an afterthought.

If you are comparing two products side by side, the glossary above and the panel section of the first guide will settle most of it. Two panels, read in the same order, answer the question faster than any review column.

Neither guide is medical advice, a diagnosis or a treatment plan, and neither recommends stopping, reducing or delaying anything a clinician has prescribed.

Neither is evidence about a particular bottle. What the second guide sets out is what the research says about the category; what GLPro contains is a separate question, and the seller has not answered it. Every trial named there carries the ingredient it studied in the same sentence as its finding, and none of them studied this capsule.

And neither replaces a conversation. The government’s guidance on supplements and diabetes is that it is very important not to replace medical treatment for diabetes with an unproven health product or practice. The second guide carries the one safety point that outranks everything else here, and it names the medicines it applies to.

ClinicalTrials.gov is the public register of clinical studies and their results, free to search. A reader who wants to know whether a finished product has ever been tested can settle it there in a minute — in either direction.

MedlinePlus keeps a plain page on dietary supplements carrying the two instructions most worth memorising: do not take a bigger dose than the label recommends, and tell the person managing your care about anything you take.

The FTC publishes the standard an advertiser is held to, which is competent and reliable scientific evidence, and states that randomised controlled human trials are generally the type of substantiation experts would require for a health benefit claim.

And the FDA page on structure/function claims is two screens long and settles most arguments about what a supplement label may say.